News for Cannara Biotech Inc. (LOVE.V)

Published at

May 1, 2025 3:00 AM

by gurufocus.com

positive

positive

Cannara Biotech Inc (LOVFF) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion

Release Date: April 29, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Cannara Biotech

LOVFF LOVE.V LOVE.CN

Read more →
Published at

May 1, 2025 2:05 AM

by gurufocus.com

neutral

neutral

Q2 2025 Cannara Biotech Inc Earnings Call Transcript

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NLOVE.V - Cannara Biotech IncQ2 2025 Cannara Biotech Inc Earnings CallApr 29, 2025 / 03:00PM GM

LOVFF LOVE.V LOVE.CN

Read more →
Published at

Apr 29, 2025 10:46 PM

by seekingalpha.com

neutral

neutral

Cannara Biotech Inc. (LOVFF) Q2 2025 Earnings Call Transcript

Cannara Biotech Inc. (OTCQB:LOVFF) Q2 2025 Earnings Conference Call April 29, 2024 11:00 AM ETCompany ParticipantsScott Carroll - VP Commercial Strategy...

LOVFF LOVE.V LOVE.CN

Read more →
Published at

Apr 28, 2025 2:46 PM

by gurufocus.com

positive

positive

Cannara (LOVFF) Sees 35% Revenue Surge in Q2 Amid National Expansion | LOVFF Stock News

Cannara Biotech Inc. (LOVFF) reported a significant financial milestone for the second quarter of 2025, with net revenues reaching C$26.6 million. This reflects

LOVFF LOVE.V LOVE.CN

Read more →
Published at

Apr 28, 2025 2:00 PM

by gurufocus.com

neutral

neutral

Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

Record Revenue: Net revenues of $26.6 million in Q2 2025, a 35% increase compared to $19.7 million in Q2 2024, driven by national brand growth and product innov

LOVFF LOVE.V LOVE.CN

Read more →
Published at

Apr 16, 2025 2:22 PM

by gurufocus.com

mixed

mixed

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025 | LOVFF Stock News

\n Cannara Biotech (TSXV: LOVE) (OTCQB: LOVFF) to release Q2 2025 financial results on April 28, 2025. Investors can participate in an earn

LOVFF LOVE.V LOVE.CN

Read more →
Published at

Apr 16, 2025 2:00 PM

by gurufocus.com

positive

positive

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025

MONTREAL, April 16, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (â\u0080\u009cCannaraâ\u0080\u009d, â\u0080\u009cthe Companyâ\u0080\u009d, â\u0080\u009cusâ\u0080\u009d or â\u0080\u009cweâ\u0080\u009d) (TSXV: LOVE) ( LOVFF) (FRA: 8CB0),

LOVFF LOVE.V LOVE.CN

Read more →
Published at

Apr 16, 2025 1:13 PM

by manilatimes.net

positive

positive

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025

**media[596622]**

LOVFF LOVE.V LOVE.CN

Read more →
Published at

Mar 24, 2025 1:44 PM

by manilatimes.net

mixed

mixed

Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors

**media[574693]**

SONY LOVFF LOVE.CN LOVE.V

Read more →
Published at

Mar 6, 2025 2:11 PM

by manilatimes.net

positive

positive

Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025

**media[559080]**

LOVFF LOVE.V LOVE.CN

Read more →
Published at

Feb 24, 2025 2:22 PM

by manilatimes.net

positive

positive

Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy

**media[548533]**

LOVFF LOVE.V LOVE.CN BMON.MX BMO

Read more →
Published at

Feb 24, 2025 2:00 PM

by gurufocus.com

positive

positive

Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy

MONTREAL, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (”Cannara”, ”the Company”, ”us” or ”we”) (TSXV: LOVE) ( LOVFF) (FRA: 8CB0), a

LOVFF LOVE.V LOVE.CN BMON.MX BMO

Read more →
Published at

Jan 27, 2025 2:00 PM

by gurufocus.com

mixed

mixed

Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025

Record Revenue: Net revenues of $25.1 million in Q1 2025, a 29% increase compared to $19.5 million in Q1 2024, driven by strong demand for Cannara's premium-gra

LOVFF LOVE.CN BMON.MX BMO LOVE.V

Read more →
Published at

Dec 16, 2024 6:30 PM

by manilatimes.net

mixed

mixed

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

**media[493838]**

LOVFF LOVE.CN LOVE.V

Read more →
Published at

Dec 12, 2024 3:53 PM

by manilatimes.net

mixed

mixed

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

**media[490661]**

LOVFF LOVE.CN LOVE.V

Read more →
Published at

Dec 12, 2024 3:33 PM

by financialpost.com

mixed

mixed

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) —

LOVFF LOVE.CN LOVE.V

Read more →
Published at

Nov 25, 2024 3:42 PM

by manilatimes.net

neutral

neutral

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market

**media[475799,475800,475801,475802,475803]**

LOVFF LOVE.V LOVE.CN

Read more →
Published at

Jul 23, 2024 2:32 PM

by financialpost.com

neutral

neutral

Cannara Biotech Reports Q3 2024 Financial Results

Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase.

LOVFF LOVE.V LOVE.CN

Read more →
Published at

Apr 29, 2024 9:01 PM

by marketscreener.com

mixed

mixed

Cannara Biotech Reports Q2 2024 Financial Results

Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0...

LOVFF LOVE.CN LOVE.V

Read more →
Published at

Dec 12, 2023 2:22 PM

by benzinga.com

positive

positive

Cannara Biotech Market Share Gains Result In Record-Setting Fourth Quarter - Cannara Biotech (OTC:LOVFF)

Thanks in part to market share gains and increasing demand for high-quality cannabis at an affordable price in Canada, Cannara Biotech Inc. (OTCMKTS: LOVFF), the vertically integrated producer of premium-grade cannabis and derivative product offerings, reported record growth in revenue and net income for its fourth quarter of 2023.

LOVFF LOVE.V LOVE.CN

Read more →